Versant Capital Management, Inc Guardant Health, Inc. Transaction History
Versant Capital Management, Inc
- $637 Million
- Q2 2025
A detailed history of Versant Capital Management, Inc transactions in Guardant Health, Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 61 shares of GH stock, worth $3,361. This represents 0.0% of its overall portfolio holdings.
Number of Shares
61
Previous 68
10.29%
Holding current value
$3,361
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding GH
# of Institutions
415Shares Held
126MCall Options Held
1.51MPut Options Held
2.35M-
Vanguard Group Inc Valley Forge, PA12.2MShares$670 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$619 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA4.98MShares$274 Million0.05% of portfolio
-
Baillie Gifford & CO4.81MShares$265 Million0.2% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.25MShares$234 Million7.85% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $5.63B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...